EBRT With or Without STAD Shows Improved 15-Year Survival in Prostate Cancer
Intermediate-Risk Prostate Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com At 15 years of follow-up, external beam radiation therapy (EBRT) with or without short-term neoadjuvant androgen deprivation therapy (STAD) led to improved prostate cancer–specific survival among patients with intermediate-risk prostate cancer (IRPC), according to data presented at the 2025 Genitourinary Cancers Symposium.1 Data from … Read more